BIOMAT Database Logo BIOMAT Database Logo

Visual compatibility of foscarnet with other injectable drugs. 1990

E Lor, and J Takagi
AIDS-Inpatient Unit, San Francisco General Hospital, CA.

UI MeSH Term Description Entries
D010746 Phosphonoacetic Acid A simple organophosphorus compound that inhibits DNA polymerase, especially in viruses and is used as an antiviral agent. Phosphonoacetate,Disodium Phosphonoacetate,Fosfonet Sodium,Phosphonacetic Acid,Phosphonoacetate, Disodium
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D004344 Drug Incompatibility The quality of not being miscible with another given substance without a chemical change. One drug is not of suitable composition to be combined or mixed with another agent or substance. The incompatibility usually results in an undesirable reaction, including chemical alteration or destruction. (Dorland, 27th ed; Stedman, 25th ed) Drug Incompatibilities,Incompatibilities, Drug,Incompatibility, Drug
D017245 Foscarnet An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV. Phosphonoformate,Phosphonoformic Acid,Foscarnet Barium (2:3) Salt,Foscarnet Calcium (2:3) Salt,Foscarnet Disodium Salt,Foscarnet Magnesium (2:3) Salt,Foscarnet Manganese (2+) (2:3) Salt,Foscarnet Sodium,Foscarnet Sodium Hexahydrate,Foscarnet Trilithium Salt,Foscarnet Tripotassium Salt,Foscarnet Trisodium Salt,Foscavir,Trisodium Phosphonoformate

Related Publications

E Lor, and J Takagi
Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration.
September 1990, American journal of hospital pharmacy,
E Lor, and J Takagi
Visual compatibility of vasopressin with other injectable drugs.
October 2005, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
E Lor, and J Takagi
Visual compatibility of dobutamine hydrochloride with other injectable drugs.
May 1984, American journal of hospital pharmacy,
E Lor, and J Takagi
Visual compatibility of amiodarone hydrochloride injection with other injectable drugs.
July 1984, American journal of hospital pharmacy,
E Lor, and J Takagi
Visual compatibility of zidovudine with other injectable drugs during simulated Y-site administration.
December 1988, American journal of hospital pharmacy,
E Lor, and J Takagi
Visual and spectrophotometric determination of compatibility of alteplase and streptokinase with other injectable drugs.
March 1990, American journal of hospital pharmacy,
E Lor, and J Takagi
Visual compatibility of hetastarch with injectable critical-care drugs.
May 1989, American journal of hospital pharmacy,
E Lor, and J Takagi
Stability of cefodizime in solution and compatibility with other injectable drugs.
August 1994, Journal of chemotherapy (Florence, Italy),
E Lor, and J Takagi
Visual compatibility of morphine sulfate and meperidine hydrochloride with other injectable drugs during simulated Y-site injection.
January 1991, American journal of hospital pharmacy,
E Lor, and J Takagi
Visual compatibility of sodium nitroprusside with other injectable medications given to pediatric patients.
August 2001, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
Copied contents to your clipboard!